Navigation Links
Essilor : First Half 2009 Results
Date:8/26/2009

ation increased revenue by 6.0%, reflecting the contributions of the businesses acquired in 2008 and in the first half of 2009. The currency effect was a positive 4.1%, lifting growth to 9.4%.

The like-for-like decrease in first-half revenue included a decline of 1.0% in the first quarter and of 0.4% in the second, reflecting the following factors:

    - The successful launch of value-added products around the
      world, including the new Crizal Forte(R) anti-reflective lens, the
      Essilor Transitions(R) VI variable-tint lens in Europe, the Xperio(TM)
      polarized lens in the United States and the new MrBlue(TM) edger.

    - Firm growth in entry-level products, where Essilor holds
      strong positions.

    - A disappointing first-quarter performance in Instruments.


    Revenue by region

    EUR millions   H1 2009  H1 2008   % Change      % Change      Change in
                                     (reported*) (like-for-like)   scope of
                                                                Consolidation

    Europe          665.1    693.5      -4.1%         -4.4%          +2.0%
    North America   718.1    617.9     +16.2%         -0.9%          +4.3%
    Asia-Pacific    170.1    146.8     +15.9%        +13.5%          +1.3%
    Latin America    60.3     60.6      -0.5%         +9.4%          +0.7%
    Laboratory
    equipment [1]    49.8**    1.4***    n.a.          n.a.           n.a.

(*) Currency effect: +4.1%. (**) The figure excludes Satisloh sales to Essilor, which totaled EUR14.8 million. (***) Satisloh was not part of the Group in first-half 2008.

Eleven acquisitions in the first half

During the first half, Essilor acquired or increased its holding in eleven companies. Together, they represent additional full-year revenue of EUR47 million for a total investment of EUR36.9 million.

    - In the United States, Essilor
'/>"/>
SOURCE Essilor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
2. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
3. Essilor Enters Bulgarian Market
4. Essilor : 2007 Results
5. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
6. Essilors 2008 First-Quarter Report
7. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
8. Essilor - First-Half 2008 Revenue
9. Essilor Steps Up its Development in Eastern Europe
10. Essilor Agrees to Acquire Signet Armorlite
11. Essilor : 2008 Revenue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...wire/--CortivaInstituteTucsonwillhostanIntroductio...attheschool,s6390EastBroadwayBlvd.location,whichwi...cticebasicmassagestrokes. ,, "Massagetherapyisa...talongwithit,"saidJoannMcMaster,presidentofCortiva...abor,s2009-2010OccupationalOutlookHandbookstatesth...
(Date:11/23/2009)...ewswire/--InasurveyofNewJerseyandPhiladelphiaregio...,72percentdonotbelieveanewhealthcarebillwouldlikel...oresultsofthelatestsurveyconductedbytheAlloySilver...toppedthelistat85percentasthebiggestnationalissue....nttocompaniesfromallpartsofNewJerseyandSoutheaster...
(Date:11/23/2009)...ience Writings at Stevens Institute of Technology ...ert Wright, journalist and founder, Bloggingheads.... the Babbio Center for Technology Management, Room... the media., In his new book "The Evolution of G...owned for his popular works on evolutionary psycho...
(Date:11/23/2009)...l errors self-reported by American surgeons are st...se findings appear today in the online edition of ...luded collaborators from Johns Hopkins and the Ame...ial study, nearly 9 percent of U.S. surgeons respo...nths prior to being surveyed. Over 70 percent attr...
(Date:11/23/2009)...s Diseases Society of America (IDSA) has asked for...e European Union to further the Society,s mission ...ithin the next 10 years, known as the 10 x ,20 Ini...identified antimicrobial resistance as one of the ...European Union report confirms there are just 15 a...
Breaking Medicine News(10 mins):Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3
... molecule that is part of a complex signaling netw...e in periventricular heterotopia (PVH), a congenit...earchers report in Neuron. PVH often leads t...ses, but is most commonly due to mutations in the ...
...tarbucks are now determined to stop the use of dai...th hormone (rBGH) at all of their stores. //Severa... cream, eggnog etc., which contain rBGH are no lon...BGH milk products to eliminate trans-fatty acids f...
... recent research finding indicates that patients w...er rate of relapse of multiple sclerosis (MS). Mul...rms the myelin sheath that covers the nerve fibres...als of Neurology. A study was conducted by them am...
...t is an act of gratitude, and Nathan Hartley is on...s one of four brothers, all who had been diagnosed...are genetic defect, in November 2003. X-linked...ses the immune system to respond abnormally to som...
...anadian scientists claim to have found a substitut...bearable side effects like nausea and fatigue. The...ournal Cancer Cell. // The scientists seemed to...and consumed. The greater advantage of DCA is its ...
... new surgical technique pioneered at the Universit... to patients with tongue cancer.// By modify...from a patient's forearm to his tongue, surgeons c...along with the tissue and skin of the forearm to r...
Other Medicine News:Health News:Missing Molecule Has Important Role in a Developmental Brain Abnormality 2Health News:Big Brother to the Rescue 2Health News:'Beavertail' Surgery Helps Tongue Cancer Patients 2Health News:'Beavertail' Surgery Helps Tongue Cancer Patients 3
(Date:11/23/2009)...23/PRNewswire-FirstCall/--WoundManagementTechnolog...viderofspecialtymedicalproducts,announcedthatithas...hensivemanagementbusinessupdatetoillustratethedeve...lesincreased33.5%to$102,926vs.Q32008salesof$77,084...$3,327,892vs.Q32008shareholderequityof$(321,257) ...
(Date:11/23/2009)...wswire-FirstCall/--CordBloodAmerica,Inc.(OTCBullet...ationcompany( http://www.cordblood-america.com )fo...biologicalinsurancepolicy,tofamiliesnationwideandi...interviewwithCEOandco-founderMatthewSchisslerisnow...ip.tv/file/2875811 . ,, Intheinterview,Mr.Schis...
(Date:11/23/2009).../PRNewswire-FirstCall/--RaptorPharmaceuticalCorp.(...edthepresentationofclinicaltrialdataonNGX426,theCo...eceptorantagonist,atthe12thInternationalConference...nNovember20-21inSanFrancisco.Theresultsofthestudyl...logyattheCenterforPainMedicineoftheUniversityofCal...
Breaking Medicine Technology:Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5No major role for fish in the prevention of heart failure 58482 1No major role for fish in the prevention of heart failure 58482 2No major role for fish in the prevention of heart failure 58482 3Combining sun sand and science in the Bahamas 10172 1Combining sun sand and science in the Bahamas 10172 2Combining sun sand and science in the Bahamas 10172 3Spallation Neutron Source first of its kind to reach megawatt power 10168 1Spallation Neutron Source first of its kind to reach megawatt power 10168 2
...to Meet Pace of Innovations and a Health Conscious...SNewswire/ -- The Food,and Drug Administration (FD...he history of healthcare, Commissioner Andrew von,... Institute,s 50th,Annual Conference April 12 in Be...ys to use its limited,financial and personnel reso...
...a 24 April 2007. Giaconda Ltd (ASX: GIA) today,ann...DA) has,approved the Company,s Investigational New...nt of MyocondaR to treat patients with,Crohn,s Dis...erculosis (MAP). , ,The Company understands that i...o be submitted to the FDA for this indication. The...
Other Medicine Technology:FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: